Viewing StudyNCT00369226



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00369226
Status: COMPLETED
Last Update Posted: 2013-07-25
First Post: 2006-08-24

Brief Title: Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease GVHD After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Hematologic Malignancies
Keywords:
Name View
GVHD View
Velcade View
Bortezomib View
Allogeneic Stem Cell Transplant View